Company news

Rhythm Biosciences Limited news in 2022

Rhythm Biosciences Limited's news releases, calls and decks from 2022, newest first.

View company

Market Update

December 14, 2022

RHY Continues Platform Expansion Program for Other Cancers

December 14, 2022

MST Access Diagnostics Forum Presentation (Amended)

December 6, 2022

MST Access Financial Diagnostics Presentation

December 5, 2022

RHY 2022 AGM Presentation

November 29, 2022

Healthcare Conference Investor Presentation

November 8, 2022

ColoSTAT Authorised For Sale In New Zealand

November 2, 2022

Rhythm Receives $2.7m R&D Tax Incentive

October 20, 2022

Director Share Sale To Institutional Funds Manager

September 8, 2022

RHY Advances Platform Expansion with Other Cancers

July 18, 2022

Application for quotation of securities - RHY

June 19, 2022

Completion of Final TGA Submission Step to Approve ColoSTAT

May 11, 2022

Rhythm Closes Final Clinical Trial Site

May 3, 2022

Appendix 4C - quarterly

April 27, 2022

Rhythm Biosciences: RHY Presentation at PAC Partners Healthcare Conference

April 5, 2022

Rhythm Biosciences - Investor Presentation

April 4, 2022

Study 7 Confirms ColoSTAT Meets Primary Endpoint

April 3, 2022

S&P DJI Announces March 2022 Quarterly Rebalance

March 4, 2022

Rhythm Biosciences - Investor Webinar Presentation

March 1, 2022

Appendix 4D and Half Yearly Report and Accounts

February 24, 2022

Rhythm Maintains Ongoing ISO13485 Certification

February 14, 2022

Placement of $6.5m to Global Institutional Funds Manager

January 5, 2022

Decks in 2022